Research and Development

Showing 15 posts of 9616 posts found.

Pfizer Sandwich image

Pfizer Sandwich site sold to private consortium

August 3, 2012 Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …

Bristol-Myers Squibb halts Hep C pill study

August 2, 2012 Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension

Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …
Daiichi Sankyo UK

Daiichi Sankyo: breaking down barriers with social media

August 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …

Olympics to kick-start research ventures

August 1, 2012 Research and Development, Sales and Marketing GSK, London 2012, Olympics, research

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …

MRN posts 533% growth in first five years

August 1, 2012 Research and Development clinical trials, growth, results

From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …

Pfizer’s RA pill impresses in Phase III

August 1, 2012 Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …

Ariad files new blood cancer drug with the FDA

July 31, 2012 Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …
tulstrup

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012 Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
david-meek

Novartis’ David Meek moves to Endocyte

July 30, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012 Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …

The fight over ‘Obamacare’ goes on

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare

The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …
anne_sutton

NHS Commissioning Board appoints key directors

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Sutton, Lyn Simpson, NHS Commissioning, PCT

The NHS Commissioning Board Authority has announced the appointment of the two director posts in the national leadership team of …

Europe looking to revamp clinical trial laws

July 25, 2012 Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …

Parexel’s BioPharm Unit to aid smaller R&D firms

July 25, 2012 Research and Development Parexel, R&D, biotech

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
The Gateway to Local Adoption Series

Latest content